PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026 PhaseV is set to showcase its innovative AI/ML solutions at key conferences in 2026, aiming to enhance clinical trial efficiency and patient outcomes.

PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026 #United_States #Boston #Clinical_Trials #PhaseV #AI/ML

Revolutionizing Clinical Trials: PhaseV's AI Conductor Streamlines Submission Workflows PhaseV has unveiled its AI Conductor platform, which automates every aspect of clinical trial workflows, from protocol drafting to FDA submission readiness.

Revolutionizing Clinical Trials: PhaseV's AI Conductor Streamlines Submission Workflows #USA #Boston #Clinical_Trials #PhaseV #AI_Conductor

At the 17th Annual SCOPE Summit, PhaseV officially launched its AI-powered Enrollment Lab, a system that replaces theoretical study planning with evidence-based certainty by leveraging real-world Electronic Health Record (EHR) data.

#AI #PhaseV #ClinicalTrials #MedTech

Revolutionizing Clinical Trials: PhaseV's New AI-Driven Enrollment Lab PhaseV presents its groundbreaking AI-based Enrollment Lab, designed to enhance clinical trial planning by utilizing real-world data for patient eligibility assessment and competitive analysis.

Revolutionizing Clinical Trials: PhaseV's New AI-Driven Enrollment Lab #USA #Boston #Clinical_Trials #PhaseV #Enrollment_Lab

PhaseV Achieves Record Growth as Biopharma Shifts Towards AI Execution for Clinical Trials PhaseV has experienced significant growth in 2025, transitioning from AI pilots to full-scale clinical execution, supported by major funding and industry partnerships.

PhaseV Achieves Record Growth as Biopharma Shifts Towards AI Execution for Clinical Trials #None #Boston #PhaseV #Biopharma #AI/ML

PhaseV Recognized with Three Major Awards for AI in Clinical Development PhaseV has garnered three prestigious awards, showcasing its leadership in applying AI/ML to enhance clinical development efficiency and success.

PhaseV Recognized with Three Major Awards for AI in Clinical Development #United_States #Boston #AI_in_Healthcare #Clinical_Trials #PhaseV

PhaseV to Showcase Cutting-Edge AI/ML Innovations for Clinical Trials at Major Biopharma Conferences PhaseV will present groundbreaking advancements in AI and ML for clinical trials at key biopharma events, highlighting their role in accelerating drug development.

PhaseV to Showcase Cutting-Edge AI/ML Innovations for Clinical Trials at Major Biopharma Conferences #USA #Boston #AI_Innovations #PhaseV #Biopharma_Events

PhaseV Teams Up with Bioforum to Streamline Clinical Trials with AI Optimization PhaseV has joined forces with Bioforum to enhance clinical trials by integrating AI-driven design optimization, promising faster results and reduced costs.

PhaseV Teams Up with Bioforum to Streamline Clinical Trials with AI Optimization #United_States #Boston #Clinical_Trials #PhaseV #Bioforum

Introducing PhaseV's AI-Based Trial Optimizer on AWS Marketplace to Transform Clinical Trials PhaseV has launched its AI-powered Trial Optimizer on AWS Marketplace, offering biopharma and CROs a robust tool to enhance clinical trial efficiency and reduce costs dramatically.

Introducing PhaseV's AI-Based Trial Optimizer on AWS Marketplace to Transform Clinical Trials #USA #Boston #PhaseV #Clinical_Development #AI_Trials

Melanie Ivarsson OBE Joins PhaseV as Advisor to Propel AI-Driven Clinical Development PhaseV welcomes Melanie Ivarsson OBE to its scientific advisory board, enhancing its AI-driven clinical development capabilities and expertise.

Melanie Ivarsson OBE Joins PhaseV as Advisor to Propel AI-Driven Clinical Development #USA #Boston #PhaseV #AI_Clinical_Trials #Melanie_Ivarsson

PhaseV Launches Revolutionary ClinOps AI Platform for Clinical Trials PhaseV unveils the ClinOps platform, leveraging AI for innovative clinical trial operations with precision in site selection and analytics.

PhaseV Launches Revolutionary ClinOps AI Platform for Clinical Trials #USA #Boston #PhaseV #AI_Platform #ClinOps

PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients #healthIT #PhaseV
www.healthcareittoday.com/?p=2523772

PhaseV Partners with Crohn's & Colitis Foundation to Innovate IBD Research Through AI Technology PhaseV has formed a strategic partnership with the Crohn's & Colitis Foundation to utilize AI/ML in enhancing IBD research and treatments.

PhaseV Partners with Crohn's & Colitis Foundation to Innovate IBD Research Through AI Technology #USA #Boston #PhaseV #Crohn's_Foundation #IBD_Plexus

PhaseV Secures $50M in Series A Funding to Revolutionize AI in Clinical Trials PhaseV has successfully completed a $50 million Series A funding round to enhance its AI platform for clinical development, supported by major investors and pharma clients.

PhaseV Secures $50M in Series A Funding to Revolutionize AI in Clinical Trials #USA #Boston #PhaseV #Series_A_Funding #AI_Clinical_Trials

PhaseV to Launch Second Webinar on Patient-Centric Approaches in Clinical Trials Join PhaseV's upcoming webinar as industry experts discuss the integration of patient-centricity and efficient designs into clinical trial processes.

PhaseV to Launch Second Webinar on Patient-Centric Approaches in Clinical Trials #United_States #Boston #Clinical_Trials #PhaseV #AI/ML_Development

PhaseV Showcases Innovative AI Solutions for Clinical Development at Upcoming Conferences Discover how PhaseV leverages AI-driven solutions to transform clinical development processes at various upcoming biotechnology events across the U.S.

PhaseV Showcases Innovative AI Solutions for Clinical Development at Upcoming Conferences #USA #New_York #AI_Solutions #Clinical_Trials #PhaseV

PhaseV Unveils Innovative AI/ML Solutions for Clinical Trials at CMO Summit 360⁰ PhaseV will showcase groundbreaking AI and ML technologies for clinical trial design and analysis at the upcoming CMO Summit in Boston, enhancing success rates.

PhaseV Unveils Innovative AI/ML Solutions for Clinical Trials at CMO Summit 360⁰ #USA #Boston #Clinical_Trials #PhaseV #AI/ML_Solutions

PhaseV and Alimentiv Collaborate to Enhance GI Clinical Trials Using Machine Learning PhaseV partners with Alimentiv to innovate GI clinical trials using machine learning, enhancing design and execution for better health outcomes.

PhaseV and Alimentiv Collaborate to Enhance GI Clinical Trials Using Machine Learning #United_States #Boston #PhaseV #Alimentiv #GI_Trials

PhaseV Collaborates with Toronto's UHN to Transform Lupus Research Through Machine Learning PhaseV and University Health Network join forces, applying machine learning to improve understanding and treatment of lupus, a complex autoimmune disease.

PhaseV Collaborates with Toronto's UHN to Transform Lupus Research Through Machine Learning #Canada #Toronto #PhaseV #Lupus #UHN

PhaseV Introduces Groundbreaking Causal Machine Learning Method at ML4H Symposium for Enhanced Patient Treatment Insights At the ML4H Symposium, PhaseV will showcase its innovative Causal Responder Detection method, revolutionizing patient treatment analysis and enhancing adaptive trial designs.

PhaseV Introduces Groundbreaking Causal Machine Learning Method at ML4H Symposium for Enhanced Patient Treatment Insights #Canada #Vancouver #Clinical_Trials #PhaseV #Causal_ML

PhaseV's Innovative Machine Learning Approach Revolutionizes Drug Development for Leading Pharma Companies Seven major pharmaceutical companies have adopted PhaseV's machine learning technology for drug development, enhancing efficiencies and precision.

PhaseV's Innovative Machine Learning Approach Revolutionizes Drug Development for Leading Pharma Companies #United_States #Boston #PhaseV #Machine_Learning #Drug_Development

Seven Leading Pharmaceutical Firms Embrace PhaseV's Advanced ML Tools for Drug Development Success Seven global pharmaceutical companies are utilizing PhaseV's machine learning technologies to revolutionize drug development processes in various therapeutic areas.

Seven Leading Pharmaceutical Firms Embrace PhaseV's Advanced ML Tools for Drug Development Success #USA #Boston #PhaseV #Machine_Learning #Drug_Development